EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 4-Nov-2026 03:16 ET (4-Nov-2026 08:16 GMT/UTC)

22-Jun-2026

Double strike on TRKC: The nobiletin-SAHA alliance

HEP Data Cooperation Journals
Peer-Reviewed Publication

A new mechanism based on a novel natural BH3 mimetic nobiletin combined with an HDAC inhibitor to synergistically regulate apoptosis and autophagy in non-small cell lung cancer (NSCLC) by down-regulating TRKC expression is provided, and a new strategy for NSCLC therapy is opened.

Journal: Chinese Journal of Natural Medicines

22-Jun-2026

Immediate treatment of moderate pre-cancerous cervical cells may be safely delayed without raising cancer risk

American College of Physicians
Peer-Reviewed Publication

A target trial emulation study found that of women with cervical intraepithelial neoplasia (CIN) grade 2 (CIN 2), a moderate form of pre-cancerous cervical dysplasia, excision within 6 months did not lower three-year cervical cancer risk compared to continued surveillance.

Journal: Annals of Internal Medicine

22-Jun-2026

Pancreatic cancer discovery advances toward first-of-its-kind clinical trial

University of Miami Miller School of Medicine
Peer-Reviewed Publication

Sylvester researchers identified IL1RAP as a key driver of pancreatic cancer treatment resistance. Backed by a V Foundation grant, the findings are advancing into a first-of-its-kind clinical trial combining IL1RAP-targeted therapy with chemoimmunotherapy before surgery.

Journal: JCI Insight

22-Jun-2026

Foundational research points to new therapeutic strategies for an emerging cancer drug

Salk Institute
Peer-Reviewed Publication

Salk Institute researchers investigated the impacts of entinostat, a drug that targets HDAC proteins, and found it inactivates DNA damage repair genes in pancreatic cancer cells. Their discovery led to new treatment strategies that pair entinostat with DNA-damaging therapies, as well as the development of a nanoparticle-based delivery approach that limits toxicity by selectively delivering entinostat to tumors. The findings could improve treatment outcomes and expand therapeutic options for pancreatic cancer, and similar strategies could be applied for treating other cancer types that resist DNA-damaging therapies.

Journal: Proceedings of the National Academy of Sciences

22-Jun-2026

New AI-powered platform helps researchers find promising cancer therapies faster

University of California - Los Angeles Health Sciences
Peer-Reviewed Publication

The technology could help researchers identify promising cancer therapies more rapidly and provide a way to test treatments on a patient's own tumor cells, helping guide more personalized treatment decisions.

Journal: Nature Protocols
Funder: Air Force Office of Scientific Research, U.S. Department of Defense

22-Jun-2026

Faster aging in younger generations linked to rise in early-onset cancer

WashU Medicine
Peer-Reviewed Publication

A new study led by researchers at WashU Medicine suggests that younger generations are aging biologically faster than their older counterparts. This faster biological aging was also linked to early-onset cancers.

Journal: Nature Medicine

22-Jun-2026

A quantum mechanics approach to artificial intelligence can improve cancer outcomes

University of Utah
Peer-Reviewed Publication

Using principles of superposition and entanglement, an interdisciplinary research team led by the University of Utah and Huntsman Cancer Institute develop an AI framework to tailor patients' cancer treatment to their entire molecular background

Journal: APL Quantum
Funder: Utah Science Technology and Research

22-Jun-2026

Dr. Theodore Scott Nowicki receives grant to advance novel CAR-T therapy for pediatric bone cancer

University of California - Los Angeles Health Sciences
Grant and Award Announcement

The award, which comes with $100,000, the highest funding level awarded through the OutSmarting Osteosarcoma program, will support Nowicki’s research into the development of a next-generation CAR-T cell therapy for osteosarcoma, the most common bone cancer in children and adolescents.

22-Jun-2026

Copper-induced cell death activates immune system, may help overcome immunotherapy resistance

University of Texas M. D. Anderson Cancer Center
Peer-Reviewed Publication

A preclinical study from researchers at The University of Texas MD Anderson Cancer Center, published today in Cell, details a connection between the immune system and cuproptosis, a type of copper-induced cell death. The findings suggest a new approach to help overcome resistance to immunotherapy.

Journal: Cell

22-Jun-2026

Wearable devices may help detect cytokine release syndrome earlier in patients receiving CAR-T therapy

The Mount Sinai Hospital / Mount Sinai School of Medicine
Peer-Reviewed Publication

Researchers at the Icahn School of Medicine at Mount Sinai have found that wearable devices may help clinicians detect cytokine release syndrome (CRS)—a common and potentially serious side effect of CAR-T cell therapy—hours earlier than standard hospital monitoring in patients with multiple myeloma, a blood cancer that begins in plasma cells in the bone marrow.

Journal: JCI Insight